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ABSTRACT
Background: The OPTIMA (MSD,
Courbevoie, France) questionnaire was
developed to promote shared decisions and
the set-up of specific micro-objectives in
clinical practice by optimizing communication
between type 2 diabetes (T2DM) patients and
their physicians. The present study aimed to
assess OPTIMA in clinical practice.
Methods: A cross-sectional multicenter
observational study was conducted in France
from 2012 to 2014. During routine
consultation, patients completed one of the
five modules of the OPTIMA questionnaire
(Physical activity, Diet, Treatment, Knowledge
of the disease or Self-monitoring of blood
glucose). The rate of SMART (specific,
measurable, acceptable, realistic, timely)
micro-objective set-up following the use of the
questionnaire was assessed. Data on how
patients felt about their diabetes management
(beliefs concerning actions, how easy they were
to do and how often they were done in practice)
were gathered. Finally, patients’ and physicians’
opinions on OPTIMA were assessed using the
PRAgmatic Content and face validity Test
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(PRAC-Test (Mapi, Lyon, France) evaluation
questionnaire.
Results: Overall, 807 patients were included by
186 physicians. While 92.7 % of consultations
led to the set-up of a micro-objective, only
22.3 % were SMART micro-objectives: Physical
activity module (34.3 %), Diet module (9.6 %),
Treatment module (16.4 %), Knowledge of the
disease module (25.2 %), and Self-monitoring of
blood glucose module (29.5 %). Among patients
completing the Physical activity module,
79.0 % reported that they believed physical
activity was useful, 35.0 % that it was easy,
and 25.8 % that they regularly practised it.
PRAC-Test results showed that OPTIMA was a
useful and easy-to-use questionnaire that
promotes communication between physicians
and their patients according to 92.8 % of
patients and 69.4 % of physicians.
Conclusion: The OPTIMA questionnaire
facilitates communication between patients
and their physicians and promotes the set-up
of micro-objectives concerning T2DM
management. The Physical activity module
was the most likely of the five modules in the
questionnaire to lead to the set-up of SMART
micro-objectives.
Funding: MSD France.
Keywords: Clinical practice; OPTIMA
questionnaire; Shared decision-making; SMART
micro-objective; Type 2 diabetes
INTRODUCTION
Regular physical activity, healthy eating, and
medications to lower blood sugar levels are vital
in the treatment and management of type 2
diabetes mellitus (T2DM) [1]. Increasing
adherence to lifestyle recommendations and
medications for diabetes is a public health
priority both economically [2] and medically
to avoid complications [3]. Lifestyle
recommendations regarding the management
of diabetes are primarily conveyed via the
patient’s physician (general practitioner—GP—
or diabetologist) during routine consultations.
However, current evidence reveals a lack of
quality communication between patients and
their physicians [3]. Patients with T2DM have
expressed difficulties when asking for emotional
support or for a more personalized way of
managing their diabetes [3]. One possible
reason for this may be the lack of physicians
encouraging their T2DM patients to ask
questions and to express concerns [4], perhaps
due to difficulties talking about sensitive issues
[5].
Furthermore, physicians tend to give vague
lifestyle goals during consultations [6]. Patients
may misunderstand these goals, because they
find them difficult to achieve. They may also be
uncertain of the extent to which they need to
follow their physician’s recommendations to
achieve the goals given to them [6]. Eventually,
these issues are likely to lead to a lack of patient
adherence [7]. To make these goals easier to
implement for physicians and patients, the
concept of SMART (specific, measurable,
achievable, realistic and timely)
micro-objectives has been proposed [8, 9]. The
use of SMART micro-objectives in practice has
led to improvements in the micro-objective
writing skills of physicians [7] and patients’
perception of being well informed [10].
Over the past few years, patients have started
to play a larger role in healthcare
decision-making, in particular, when it comes
to diabetes management [11, 12]. In parallel,
the American Diabetes Association and the
European Association for the Study of Diabetes
released a position statement recommending
that diabetes care be individualized and
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consider the needs, preferences, and tolerances
of each patient [11]. The two associations
further noted that decision-making tools may
help physicians gauge their therapeutic choices
[11]. The ability of such tools to encourage the
active involvement of patients in the
decision-making process is well established,
especially in regard to detail-oriented tools [13,
14]. To date, however, there are no validated
tools designed to help patients with T2DM
communicate with their physician to establish
effective diabetes management plans.
The OPTIMA (MSD, Courbevoie, France)
questionnaire has been developed to fill this
gap. Its purpose is to enable patients to recall
personal beliefs and lifestyle behaviors, a
process which ‘‘optimizes’’ communication
between the patients and their physicians
during the consultation. Patient responses to
the questionnaire are used to facilitate the
set-up of personalized and agreed-upon
SMART micro-objectives. The questionnaire is
made up of five modules, each specifically
focused on one key area in T2DM
management, either (1) physical activity, (2)
diet, (3) treatment, (4) knowledge of the disease,
or (5) self-monitoring of blood glucose.
The aim of this study was to assess the use of
the OPTIMA questionnaire in routine clinical
settings to assist physicians in identifying and
setting up appropriate SMART micro-objectives
(1) by analyzing the rate of set-up of SMART
micro-objectives following the use of different
OPTIMA modules by physicians during
consultations; (2) by analyzing data from
patients’ responses to the OPTIMA modules
compared to how patients’ beliefs about the
usefulness of an action, how easy they thought
it was to perform, and how often they actually
did it in their everyday lives; (3) by examining
the opinions of patients and physicians on the
use of the OPTIMA questionnaire.
METHODS
Study Design and Setting
The study was a cross-sectional multicenter
observational study conducted in France from
2012 to 2014 involving patients presenting at
their general practitioners (GPs) and
diabetologists for a routine consultation.
Physicians who agreed to participate were
given guidance on the study as part of their
onboarding pack. Within this pack, general
information about the study was given
including recommendations on the
administration of the OPTIMA questionnaire
and the completion of The PRAgmatic Content
and face validity Test [PRAC-Test (Mapi, Lyon,
France)]. Each physician had to recruit five
patients consecutively over a 5-day period in
the following order: the first two patients were
to be randomly assigned to one of four OPTIMA
modules (either Physical activity, Diet,
Treatment or Knowledge of the disease). A
predefined randomization process at the
physician level was used to ensure a minimum
of 100 patients for each of these modules. The
third patient was to be assigned to the
Self-monitoring of blood glucose module of
OPTIMA. The fourth and fifth patients could
choose which of the five OPTIMA modules they
wanted to fill out. Patients were asked to
complete the module alone in the waiting
room or the consultation room. The physician
could eventually finish the completion of the
questionnaire with the patient during the
consultation. Based on patient responses to
the module, and discussion with their
patients, physicians identified and set up a
micro-objective. Then, the physician informed
the patients about the study and invited them
to participate. Upon patient’s agreement and
after verification of patient’s eligibility, the
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physician then attributed an identification
number to each of their patients and
completed the study documents including the
PRAC-Test evaluation form, patient medical
form, and a form on which they noted
whether they had set up a micro-objective
with their patient and if so, described the
micro-objective in depth. Patients completed
the PRAC-Test (version for patient). In case the
patient refused to participate, the physician had
to destroy all the documents completed by the
patient.
To recreate real world settings, physicians
were not given any specific guidance before the
study began on how to set up SMART
micro-objectives with their patients after the
latter had finished the OPTIMA module.
To minimize bias in the completion of the
questionnaire and the set-up of SMART
micro-objectives, patients were given the
module of the OPTIMA questionnaire to
complete before being informed of the study.
A scientific committee was established at the
onset of the project to provide methodological,
scientific and clinical support and expertise at
the milestones of the project. The scientific
committee included four members, two
diabetologist specialists working in clinical
practice, one expert methodologist in




Diabetologists and GPs were recruited from
the network of the contract research
organization in charge of fieldwork. They
were randomly selected. Participation in the
study was voluntary, after having been
informed about the study objectives, process,
and their role.
Patients
Patients were recruited by the diabetologists and
GPs during a routine, spontaneous consultation.
T2DM patients aged 35 years or above, with
glycated hemoglobin (HbA1c) between 6.5%
and 9.5%, and who had not achieved their
HbA1c target set-up with their physician were
eligible for study inclusion. They must have been
receiving oral hypoglycemic agents (OHAs) for at
least 1 year, without glucagon-like peptide-1
(GLP-1) analogs and without insulin.
Sample Size
The sample size was calculated to estimate the
rate of consultations ending with the set-up of a
micro-objective within a given confidence
interval (CI). Assuming a rate of between 50%
and 95%, a sample of 100 patients per module
would be needed to estimate the rate with
half-length of the CI less than or equal to 9.8%.
The type 1 error rate was set at 5%.
Also, 100 patients were assigned to the
Self-monitoring of blood glucose module to
sharpen the estimation in this particular
module, and 400 patients could freely choose
which module they wished to complete. Two
hundred physicians were targeted to recruit
these 1000 patients.
Measures
Socio-demographic, clinical and biological data
were collected for all patients from their patient
records. Basic demographic data were collected
for physicians.
OPTIMA Questionnaire
The OPTIMA questionnaire has been developed
following a robust qualitative methodology
involving patients with T2DM, GPs and
diabetologists [The questionnaire has been
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provided (in French) as supplementary material]
[15, 16]. The qualitative analysis identified five
well-known key areas for T2DM patients and
physicians: physical activity, diet, treatment,
knowledge of the disease and self-monitoring of
blood glucose [15, 16]. A specific module
containing between 8 and 21 items was
developed around each of these key area (Fig. 1).
Each item focused on a specific activity, for
example, ‘Moving as much as possible in the
house’. Based upon an existing framework for
patient-physician communication highlighting
the importance of ‘beliefs’ and ‘skills’ [17], each
item were designed around domains so that
patients were able to describe their ‘beliefs’
about the activity’s utility for controlling their
T2DM, how ‘easy’ they thought the activity was to
do and, where applicable, their ‘actions’ in their
day-to-day lives in relation to each activity.
PRAC-Test and Patient-adapted PRAC-Test
The PRAC-Test was used to assess physicians’
opinions about the OPTIMA questionnaire [18].
The PRAC-Test included 33 items that aimed to
evaluate physicians’ interest in the tool, the
limitations they thought it had, how useful
they thought it was, how long it took them to
complete, how easy it was for them to use it and
their intentions for using OPTIMA in their
clinical practice in the future.
A version of the PRAC-Test was adapted for
use with patients. It included the following
three items: (1) ‘easiness of understanding of
the questionnaire’, (2) ‘usefulness of the
questionnaire’ and (3) ‘whether the
questionnaire facilitates communication
between the patient and the physician’.
Analysis
All patients who met inclusion criteria and for
whom a completed micro-objective form was
available were included in the analysis. Patients
were divided into two analysis sets: the Imposed
OPTIMA Analysis Set (IOAS) included patients
who had been assigned the module; the Free
1.A. Moving as much as possible in the house is: 
Very difficult for 
me  
Difficult for me Neither difficult nor 
easy for me 
Easy for me Very easy for me 
1 2 3 4 5















Very useful for 
controlling my 
diabetes 
1 2 3 4 5
1.C. Moving as much as possible in the house: 
I never do  I do rarely I do sometimes I do often I do always 
1 2 3 4 5
Note: Taken from the French version of the OPTIMA questionnaire. English translations for examples 
only. Linguistic validation of the questionnaire has not been conducted.
Fig. 1 OPTIMA questionnaire item example (Physical activity module, item 1)
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OPTIMA Analysis Set (FOAS) included patients
who freely chose their OPTIMA module.
The scientific committee reviewed all the
micro-objectives reported by physicians to
distinguish SMART micro-objectives from
non-SMART micro-objectives.
The rate of consultations leading to the
set-up of a SMART micro-objective was
calculated by analysis set and by module, and
a two-sided 95% CI was estimated using a
normal distribution approximation. Univariate
logistic regression models were used to estimate
the odds of establishing SMART
micro-objectives between modules and
between analysis sets. The type 1 error rate of
statistical tests was set to 5%.
Patient data were described according to the
analysis sets and overall. Responses to the
OPTIMA items were described using
frequencies and percentages for all positive
response options: for the ‘easiness’ domain,
positive responses were ‘easy’ or ‘very easy’; for
the ‘beliefs’ domain, positive responses were
‘useful’ or ‘very useful’; and for the ‘actions’
domain, positive responses were ‘often’ or
‘always’.
PRAC-Test items were described for patients
and physicians, and also according to physician
specialty (GPs or diabetologists) using
frequencies and percentages for all positive
response options.
All analyses were performed using SAS
software, version 9.4 of the SAS System for
Windows, SAS Institute Inc., Cary, NC, USA.
RESULTS
Study Population
A total of 186 active physicians recruited 829
patients. Out of these 829 patients, 807 (97.3%)
patients met study inclusion/exclusion criteria
and had complete data for the OPTIMA
questionnaire and the micro-objective form,
and were included in the analysis. Of these
807 patients, 511 (63.3%) were assigned an
OPTIMA module, and 296 (36.7%) freely chose
their module. The proportions of patients
assigned to each OPTIMA module as well the
proportions of patients freely choosing their
module reflected the sampling design. The
proportions of patients who freely chose each
OPTIMA module were distributed unevenly,
with a higher number completing Diet
(35.8%) and Physical activity (31.4%) modules
compared to the other modules (all\15%).
The consecutive recruitment of patients over
a 5-day period for each physician proved to be
difficult for many physicians, either due to
patients’ refusal, or patients not meeting the
eligibility criteria in this timeframe. Therefore,
the recruitment period had to be extended.
However, the target sample size was still not
reached at the end of the extended inclusion
period.
Patient and Physician Characteristics
Patient socio-demographics and clinical
characteristics are described in Table 1. There
were no substantial differences between the
IOAS and the FOAS samples. Overall, patients
were representative of a T2DM population
orally treated in France. Patients were mostly
male (60.5%) with a mean age of 63.9 years. A
majority of patients (62.0%) were retired, and
30.0% were employed. The mean duration of
diabetes was 10 years. Cardiovascular risk
factors were: hypertension (140/90 mmHg):
66.8%, obesity: 44.5%, and smoking: 13.6%.
The majority of patients were being treated with
either one (35.2%) or two (42.3%) OHAs and by
design, no patients were being treated with
insulin or GLP-1 analogs. Metformin was the
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Table 1 Patient socio-demographics and clinical characteristics
Total (N5 807) IOAS (N5 511) FOAS (N5 296)
OPTIMA module completed (%)
Physical activity module 22.6 17.4 31.4
Diet module 25.0 18.8 35.8
Treatment module 17.5 19.0 14.9
Knowledge of the disease module 14.4 16.2 11.1
Self-monitoring of blood glucose module 19.6 28.0 5.1
Several modules 1.0 0.6 1.7
Age [mean years, (SD)] 63.9 (10.4) 64.3 (10.5) 63.2 (10.1)
Male (%) 60.5 61.4 58.8
Education level (%)
Vocational certiﬁcate (BCAP/BEP) 62.9 64.0 61.1
Professional certiﬁcate (CBAC) 36.8 35.6 38.9
Missing 0.2 0.4 0.0
Professional status (%)
Employed 30.0 27.8 33.8
Unemployed 4.7 4.5 5.1
Retired 62.0 64.4 57.8
Disabled 3.2 3.1 3.4
Missing 0.1 0.2 0.0
Time since diabetes diagnosis in years (%)
\5 years 22.2 22.5 21.6
5–10 years 35.2 34.8 35.8
[10 years 40.9 40.7 41.2
Time since diabetes diagnosis [mean years, (SD)] 10.0 (6.8) 10.0 (6.8) 10.1 (6.7)
BMI (%)
Underweight (\25) 16.2 17.0 14.9
Normal (25–30) 39.3 39.9 38.2
Obese (C 30) 44.5 43.1 47.0
Smoking status (%)
Non-smoker 65.1 65.4 64.5
Smoker 13.6 12.7 15.2
Former smoker 21.3 21.9 20.3
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most prescribed drug (82.7%), followed by
sulfonylureas (49.6%), DPP4 inhibitors
(40.4%), glinides (10.8%), and a-glucosidase
inhibitors (2.9%).
Physicians were mostly male (65.6%) with a
mean age of 53 years. The majority were GPs
(78.5%), and 16.7% were diabetologists, seeing
an average of 15 diabetic patients per week
(GPs) and 28 diabetic patients per week
(diabetologists).
Rates of SMART Micro-Objective set-up
after using the OPTIMA Questionnaire
The rates of SMART micro-objectives set-up after
using the OPTIMA questionnaire are reported in
Table 2. Table 3 provides some examples of
SMART micro-objectives per module that were
established after OPTIMA completion. While the
vast majority of visits (92.7% with a 95% CI:
90.9–94.5) ended with the set-up of a
micro-objective, the rate of SMART
micro-objective set-up was only 22.3% overall.
The rates of SMART micro-objective set-up were
similar for the IOAS and FOAS (21.2% and
24.2%, respectively; OR = 1.19, p = 0.34).
Among the patients of the FOAS and IOAS,
rates of SMART micro-objective set-up were
highest in the FOAS for the Physical activity
module (42.5% and 25.6%, respectively) and the
Self-monitoring of blood glucose module (42.9%
and 28.1%, respectively); rates were the lowest
for the Treatment module (11.4% and 18.8%,
respectively) and Diet module (10.7% and 8.4%,
respectively). Regardless of whether patients
were assigned to their module or freely chose
it, patients completing the Physical activity
module were five times more likely to establish
a SMART micro-objective with their physician
compared to those completing the Diet module
(OR = 5.00, p\0.001) and about three-times
more than those completing the Treatment
module (OR = 2.63, p\0.001).
Responses to the OPTIMA Questionnaire
Median percentages of patient positive
responses to the domains of the OPTIMA
items per module are reported in Fig. 2.
Table 1 continued
Total (N5 807) IOAS (N5 511) FOAS (N5 296)
Blood pressure in mmHg (%)
C130/80 84.9 84.0 86.5
C140/90 66.8 67.3 65.9
HbA1c, [mean %, (SD)] 7.8 (0.6) 7.8 (0.6) 7.8 (0.6)
Total cholesterol [mean g/L, (SD)] 1.9 (0.4) 1.9 (0.4) 1.9 (0.4)
LDL [mean g/L, (SD)] 1.1 (0.4) 1.1 (0.4) 1.1 (0.3)
HDL [mean g/L, (SD)] 0.5 (0.2) 0.5 (0.2) 0.5 (0.2)
Triglycerides [mean g/L, (SD)] 1.6 (0.9) 1.6 (0.9) 1.7 (0.9)
IOAS Imposed OPTIMA Analysis Set, FOAS Free OPTIMA Analysis Set, SD standard deviation, BMI Body Mass index,
HbA1c glycated hemoglobin, LDL low-density lipoprotein, HDL high-density lipoprotein, CAP Certiﬁcat d’Aptitude
Professionnelle (Youth Training (NVQ Level 1,2), BEP Brevet d’Etudes Professionnelles (vocational high school), BAC
Baccalaure´at (bachelor degree)
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Physical Activity Module
A large majority of patients reported positive
beliefs for all 13 activities of the Physical
activity module, ranging from 65.4% for
‘Gardening’ to 85.7% for ‘Going for walks on
foot or bicycle rides’. Indications of ‘easiness’
for these activities were less often reported,
ranging from 23.1% for ‘Doing a sports activity’
to 52.7% for ‘Moving as much as possible in the
house’. Indications of actually performing these
activities, ‘actions’, were less often reported and
ranged from 8.2% for ‘Using an exercise bike’ to
47.3% for ‘Moving as much as possible in the
house’.
Diet Module
A majority of patients indicated positive beliefs
for most activities of the Diet module, ranging
from 32.2% for ‘Accepting to eat without
pleasure’ to 95.5% for ‘Managing my diet’.
Indications of ‘easiness’ for these activities were
reported by a minority of patients, ranging from
6.9% for ‘Losing weight’ to 71.8% for ‘Reducing
alcohol with meals’. Indications of actually
performing these activities, ‘actions’, were also
infrequently reported, ranging from 21.8% for
‘Declining non recommended food for my
diabetes when I am invited’ to 73.8% for
‘Reducing alcohol with meals’.
Treatment Module
A large majority of patients reported positive
beliefs for most activities of the Treatment
module, ranging from 52.5% for
‘Understanding how each medicine works for
Table 2 Rate of SMART micro-objective set-up
OPTIMA module Total (N5 807) IOAS (N5 511) FOAS (N5 296)
n % [95% CI] n % [95% CI] n % [95% CI]
All modules 173 22.3 (19.4; 25.3) 104 21.2 (17.6; 24.8) 69 24.2 (19.2; 29.2)
Physical activity module 58 34.3 (27.2; 41.5) 21 25.6 (16.2; 35.1) 37 42.5 (32.1; 52.9)
Diet module 19 9.6 (5.5; 13.7) 8 8.4 (2.8; 14.0) 11 10.7 (4.7; 16.6)
Treatment module 23 16.4 (10.3; 22.6) 18 18.8 (10.9; 26.6) 5 11.4 (2.0; 20.7)
Knowledge of the disease module 28 25.2 (17.1; 33.3) 18 22.8 (13.5; 32.0) 10 31.3 (15.2; 47.3)
Self-monitoring of blood glucose module 44 29.5 (22.2; 36.9) 38 28.1 (20.6; 35.7) 6 42.9 (16.9; 68.8)
IOAS imposed OPTIMA analysis set, FOAS free OPTIMA analysis set
Table 3 Examples of established SMART
micro-objectives
Physical activity module
Do 30 min using the exercise bike every day
Walk for 30 min per day
Diet module
Reduce alcohol intake to two glasses per day
Reduce from 4 to 2 pastries per week
Treatment module
Know the role of your medicines and the times to take
them
Take your medicines without forgetting any
Knowledge of the disease module
Know your Hba1c level and your blood sugar target
Know your blood pressure
Self-monitoring of blood glucose module
Measure you blood sugar after lunchtime meals
Measure your blood sugar every morning for 15 days
Hba1c Glycated hemoglobin
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my diabetes’ to 95.0% for ‘Taking my medicines
everyday’. Indications of ‘easiness’ for these
activities were less often reported and ranged
from 29.8% for ‘Understanding how each
medicine works for my diabetes’ to 70.2% for
‘Remembering to take my medicines’.
Indications of actually performing these
activities, ‘actions’, were reported by a
majority of patients, ranging from 42.6% for
‘Finding the answers to questions I have about
my medicines’ to 93.6% for ‘Taking my
medicine every day’.
Knowledge Module
A large majority of patients reported positive
beliefs for all activities of the Knowledge
module, ranging from 57.8% for ‘Knowing my
target blood pressure’ to 97.4% for ‘Bringing
down my level of sugar in the blood’.
Indications of ‘easiness’ for these activities
were less often reported and ranged from
12.1% for ‘Bringing down my level of sugar in
the blood’ to 72.4% for ‘Knowing my blood
pressure’. ‘Actions’ were reported by 39.7% of
patients in response to the question ‘Bringing
down my level of sugar in the blood’.
Self-Monitoring of Blood Glucose Module
A large majority of patients reported positive
beliefs for all activities of the self-monitoring of
blood glucose module, ranging from 62.0% for
‘Withstanding pain when I prick my fingertip’
to 96.2% for ‘Changing my diet to correct my

















Fig. 2 Median percentage of patients responding positively to domains of OPTIMA questions per module
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these activities were reported less often, ranging
from 24.7% for ‘Changing my diet to correct my
high blood sugar’ to 63.9% for ‘Withstanding
pain when I prick my fingertip’. Indications of
actually performing these activities, ‘actions’,
were also reported less often, ranging from
20.3% for ‘Increasing my physical activity to
correct my high blood sugar’ to 65.8% for
‘Withstanding pain when I prick my fingertip’.
Opinions About the OPTIMA
Questionnaire
Patients’ Opinions
The OPTIMA questionnaire was considered
‘easy to understand’ (responses ‘yes’ or ‘mostly
yes’) by a large majority of patients (91.2%); this
was similar across all modules. In decreasing
order, these were: physical activity (96.2%), diet
(92.6%), treatment (91.5%), self-monitoring of
blood glucose (89.9%), and knowledge of the
disease (81.9%).
Also, across all modules, a large majority of
patients (92.8%) responded positively in regard
to whether the module ‘promoted
communication with [their] physician’. In
decreasing order, these were: physical activity
(97.8%), diet (94.6%), self-monitoring of blood
glucose (91.1%), knowledge of the disease
(89.7%), and treatment (88.7%).
Last, across all modules, a large majority of
patients (88.7%) responded positively in terms
of the ‘usefulness’ of the module. In decreasing
order, these were: physical activity (95.1%), diet
(91.6%), knowledge of the disease (85.3%),
self-monitoring of blood glucose (84.8%), and
treatment (83.0%).
Physicians’ Opinions
The OPTIMA questionnaire was considered
‘easy to understand’ (responses ‘yes’ or ‘mostly
yes’) by a majority of GPs and diabetologists
(69.2% and 77.4%, respectively). A majority of
GPs and diabetologists responded positively in
regard to whether the questionnaire ‘promoted
communication with [their] patients’ (70.5%
and 67.7%, respectively). Just over half of all
GPs and diabetologists responded positively in
regard to whether the questionnaire was ‘useful’
(66.4% and 54.8%, respectively).
A majority of GPs and diabetologists
reported that the tool would be of benefit to
patients (69.9% and 67.7%, respectively) and to
physicians (54.1% and 58.1%, respectively). The
most frequently reported uses of the tool were
to ‘help or follow observance or adherence’
(71.2% of GPs and 80.6% of diabetologists) and
to ‘help adapt treatment’ (41.8% of GPs and
32.3% of diabetologists).
Intention to use the OPTIMA questionnaire
to any extent was highly reported by both GPs
(95.5%) and diabetologists (92.5%). Intention
of use for ‘a majority’ or ‘all’ of patients was
reported as 55.4% for GPs, and 23.1% for
diabetologists.
Most physicians (41.9%) reported that the
questionnaire required an additional 15–30 min
of consultation time (including explanation,
administration of the questionnaire, dialogue,
and micro-objective set-up). The remaining
physicians reported either requiring less than
15 additional minutes (33.9%) or more than 30
additional minutes (0.5%) (23.7% did not
answer this question). Physicians expressed
that the required additional time was quick
(45.2%) or not quick (26.3%) (23.1% did not
answer this question).
DISCUSSION
This study aimed to assess the use of the
OPTIMA questionnaire in routine clinical
settings as well as the set-up of SMART
micro-objectives following its use. Prior to the
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analysis, an in-depth review of all
micro-objectives by the scientific committee
ensured that clinically meaningful SMART
micro-objectives were distinguished from
non-SMART micro-objectives. For example, a
SMART micro-objective for the Physical activity
module could be to walk for 30 min every day,
or for the Diet module to reduce alcohol intake
to two glasses per day. The rate of SMART
micro-objective set-up was 22.3% overall. This
rate of SMART micro-objective set-up was
observed without any specific training given to
physicians on the setting of SMART
micro-objectives, which explains why the rate
of SMART micro-objective set-up was much
lower than the rate of any type of
micro-objective being set up, whether SMART
or not (92.7%). In fact, the micro-objectives
recorded in the study varied considerably in
terms of their content and specificity. The
difference between the rates of any type of
micro-objective set-up and SMART
micro-objective set-up reveals a potential for
improvement on the rate of SMART
micro-objective set-up after having
administered specific training for physicians
[19]. Educational interventions for physicians
and nurses have been shown to increase the
setting of SMART collaborative goals [7, 10].
The rates of SMART micro-objective set-up
were generally higher for patients who completed
a module of their choice than for patients who
had been assigned a specific module. Although
the difference was not significant, the trends of
higher rates of SMART micro-objective set-up
among patients who choose their module may
suggest increased success when patients are able
to play an active role at an early stage of the
clinical decision-making process. The difference
between rates of SMART micro-objective set-up
was especially apparent for the Physical activity
module.
The OPTIMA questionnaire exposed specific
gaps in T2DM management in regard to key
activities that are important to patients and
physicians. These gaps were characterized by a
high report of patient beliefs that specific
activities were useful in controlling their
diabetes in contrast to the low reports that
these activities were easy to perform and of
actually implementing them in day-to-day life.
For example, in terms of how easy it was for
patients to perform activities, the maximum
percentage of patients reporting that an activity
was easy was never more than 72.4%. This was
the case throughout all modules. In other
words, for every activity described within the
OPTIMA questionnaire, at least 27.6% of
patients expressed that it was not easy to
perform. These reports may highlight the
presence of specific barriers that affect a large
proportion of T2DM patients and inhibit them
from performing particular activities. If this is
the case, the identification of these barriers may
lead to more effective T2DM management [20].
Report of implementing activities was low
for the majority of modules. Physical activities
appeared to be the least implemented of all with
no more than half (47.3%) of all patients
reporting often implementing any type of
physical activity. In contrast, actions reported
in the Treatment module in regard to taking
medicines were more frequently reported. These
results are consistent with a previous large study
of diabetic patients which found that patients
adhered to medications and dietary plans but
failed to adhere to exercise recommendations
[3].
The relationship between the report of
‘easiness’ and the report of actually
implementing activities suggests an interesting
tradeoff in the eyes of patients. For all the
modules except Physical activity, patients often
implemented ‘actions’ despite expressing a
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degree of difficulty. In contrast, patients in the
Physical activity module reported often not
doing tasks even if these were perceived as
relatively easy (see Fig. 2). Such reports may
indicate that patients were transitioning
through earlier stages of behavioral change
when they completed the OPTIMA Physical
activity module, as previously postulated in
the Prochaska and DiClemente’s stages of
change model [21]. The role of physicians who
exercise in informing and promoting behavioral
change is likely to be key in successfully
engaging patient motivation and involvement
[22]. Future qualitative research could look
deeper into this perceived tradeoff between
‘easiness’ and ‘actions’ concerning the
implementation of healthy lifestyle behaviors.
According to the PRAC-Test, GPs and
diabetologists found the OPTIMA
questionnaire useful for monitoring
compliance or adherence and for adapting
treatment. They believed that it was an easy
questionnaire to implement, that it was useful
in their clinical practice and that it promoted
communication with their patients. Patients’
opinions regarding these three aspects were
overall more positive than those of physicians.
Patient opinions were the highest toward the
Physical activity and Diet modules.
Results suggest that the Physical activity
module is the most likely module to be of
benefit to patients. First, the success of setting up
SMART micro-objectives in the Physical activity
module suggests that physicians and patients can,
together, set up meaningfulgoals. Second, the gap
between ‘easiness’ and ‘actions’ in the Physical
activity module suggests that this is a fruitful area
in which physicians and patients can set up
feasible SMART micro-objectives. Third, the
choice of this module by a large proportion of
patients may indicate patient demand to focus on
this area. Last, this appeared to be the most
well-received module, as indicated by the
highest percentage of patients’ reporting of
usefulness on the PRAC-Test. Successful
implementation of SMART micro-objectives may
not only have benefit in one specific area. It has
been suggested that because of increased patient
empowerment, patients may actively engage in
other healthy lifestyle behaviors in a virtuous
cycle of improvements [23].
The study presents some limitations. As the
study was conducted in a single country only,
the findings are likely to not be generalizable as
diabetes management, and patient attitude
might differ from one country to another.
Also, following the study design, physicians
used more than one OPTIMA module, so
physician opinions collected using the
PRAC-Test could not be differentiated by
module. Also, one could not tell from the
current study whether the rate of SMART
micro-objective set-up would have been
different without the OPTIMA questionnaire.
Finally, we acknowledge that the method of
convenience sampling may have introduced
bias in study results, but was the method
ensuring minimal additional study related
procedures into the real world setting. The
method was also adapted for physicians seeing
only a few diabetic patients, for whom it would
have been difficult to generate lists of patients
and randomize at that level.
The results of this study call for the
prioritization of promoting physical activities
for the management of T2DM. We propose that
a decision-making tool such as the OPTIMA
questionnaire be used in combination with the
establishment of SMART micro-objectives.
Evidence suggests that shared decisions lead to
increased patient adherence to
recommendations across different disease areas
[14]. Furthermore, patients’ desire for active
involvement in their own healthcare has been
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shown to be positively associated with control
of their diabetes [24]. Future interventional
research is now needed to provide evidence
that the use of OPTIMA questionnaire increases
set-up, retention, and completion of SMART
micro-objectives and eventually leads to
improved health outcomes.
CONCLUSION
The OPTIMA questionnaire is a useful and easy
tool that could facilitate the communication
between patients and their physicians, and
promote the set-up of micro-objectives for
T2DM management following consultations.
In particular, the Physical activity module of
the questionnaire was the most likely to lead to
the set-up of SMART micro-objectives. Patients
had high beliefs regarding the importance of
specific activities for the management of their
diabetes, yet they found activities difficult to
perform, and consequently, did not perform
them often. This was particularly the case for
patients completing the Physical activity
module. Future studies may consider giving
specific guidance to physicians on how to
formulate SMART micro-objectives to increase
the set-up of SMART micro-objectives.
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